IGF1 and cancer: Furthermore, other mouse lines with adult‐onset reduction in the GH/IGF‐1 axis also have shown controversial results with respect to cancer resistance as lifespan extension seen in LID5m females was not associated with reduced cancer incidence (Ashpole et al., 2017).